Skip to main content

Waters Acquires Chromatography Instrument Maker

NEW YORK (GenomeWeb News) – Waters has acquired privately held Thar Instruments for an undisclosed sum, the Milford, Mass., maker of chromatography and mass spectrometry instruments said after the close of the market on Monday.

Thar makes supercritical fluid chromatography instrument systems that are used for separation, isolation, and quantification of chemical compounds. According to Waters, the technology is similar to liquid chromatography but uses carbon dioxide as the main mobile phase, which offers environmental and cost benefits compared to liquid chromatography solvents.

"By combining Thar's advanced SFC instrumentation with Waters' chromatography expertise, Waters is committed to bringing the benefits of SFC to more laboratories for analytical and purification technologies worldwide," Rohit Khanna, vice president of worldwide marketing for Waters, said in a statement.

Waters had made an equity investment in Pittsburgh-based Thar in June 2007.

Thar had revenues of roughly $18 million in 2008, and Waters expects the acquisition to be neutral to its earnings in 2009.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.